ArticleApplied health economics and health policy2023

Value for Money of CAR-T Cell Therapy for Patients with Diffuse Large B-cell Lymphoma in China: Evidence from a Cost-Effectiveness Analysis.

Weijia Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.